XML 41 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Organization and Description of the Business (Details)
$ in Millions
May 09, 2019
USD ($)
item
shares
Number of board of directors appointed by C3J 5
Number of board of directors 7
C3J [Member]  
Number of shares issued per common stock outstanding | shares 6,906.0000
Reverse stock split ratio 0.0714
Anticipated purchase of common shares upon completion of merger | $ $ 10.0
Percentage of ownership 76.00%
AmpliPhi Biosciences Corporation [Member]  
Percentage of ownership 24.00%